Schering To Acquire Full U.S. Marketing Rights To Integrilin From Millennium

Deal will build on Schering’s foundation in cardiovascular care and provide increased flexibility for sale force effectiveness and promotions, the company says. For Millennium, move will provide a revenue stream to support Velcade and products in development.